Breast self-examination prevalence and determinants in low- and middle-income countries: an umbrella review of systematic reviews and meta-analyses

低收入和中等收入国家乳房自检普及率及其决定因素:系统评价和荟萃分析的伞状综述

阅读:2

Abstract

BACKGROUND: Low- and middle-income countries (LMICs) face a dual burden of infectious and chronic diseases, including breast cancer. Breast self-examination (BSE) is a vital tool for early detection, improving outcomes, and reducing mortality. Assessing its prevalence and determinants in LMICs is crucial for enhancing early diagnosis and treatment. METHODS: A comprehensive search was conducted across PubMed, Web of Science, Scopus, Cochrane, and Google Scholar using PICO criteria to identify systematic reviews and meta-analyses on breast self-examination in Low- and middle-income countries. Methodological quality was assessed using the AMSTAR tool. A random-effects meta-analysis pooled estimates, with heterogeneity (I (2)) and publication bias (funnel plot) evaluated. Forest plots presented pooled prevalence with 95% confidence intervals (CI). RESULTS: This umbrella review included 10 studies (110,622 participants). The pooled BSE prevalence was 32.15% (confidence interval: 22.61-40.75), with high heterogeneity (I (2) = 100%, p = <0.001). Significant determinants included BSE knowledge (OR = 3.95; 95% CI: 3.02-4.87), a positive attitude (OR = 2.73; 95% CI: 2.02-3.45), and a family history of breast cancer (OR = 1.81; 95% CI: 1.23-2.38). CONCLUSION: The prevalence of breast self-examination (BSE) in low and middle-income countries (LMICs) remains relatively low at 32.15%. Key factors influencing BSE practice include knowledge, attitudes, and family history of breast cancer. To enhance BSE practice, targeted strategies such as public awareness campaigns, training for healthcare providers, and incorporating family history assessments are essential. Additionally, strengthening research and policy initiatives can help address existing gaps in awareness, promote early detection, and improve breast cancer outcomes in low and middle-income countries. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42023491634.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。